Pullen Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Sell
6,267
-113
-2% -$30.6K 0.84% 48
2025
Q4
$1.6M Sell
6,380
-121
-2% -$32.1K 0.84% 45
2025
Q3
$1.87M Buy
6,501
+60
+0.9% +$16.1K 1.01% 38
2025
Q2
$1.69M Sell
6,441
-23
-0.4% -$5.6K 1.02% 44
2025
Q1
$1.5M Sell
6,464
-454
-7% -$110K 0.95% 43
2024
Q4
$1.59M Sell
6,918
-342
-5% -$78.5K 1.03% 34
2024
Q3
$1.62M Buy
7,260
+209
+3% +$45.9K 1.19% 28
2024
Q2
$1.43M Sell
7,051
-313
-4% -$63.7K 1.19% 31
2024
Q1
$1.61M Buy
+7,364
New +$1.62M 1.36% 21

Other funds holding LH

Pullen Investment Management's LH Position: Q1 2026 in Review

Pullen Investment Management reduced its Labcorp (LH) stake by 1.8% in Q1 2026, selling an estimated $30.6K and leaving 6,267 shares worth $1.67M. The position accounts for 0.84% of the portfolio, ranked #48.

Pullen Investment Management first reported a position in LH in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.87M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Pullen Investment Management held 6,267 shares of Labcorp worth $1.67M as of Q1 2026.
  • Pullen Investment Management sold 113 Labcorp shares in Q1 2026, an estimated $30.6K.
  • Labcorp made up 0.84% of Pullen Investment Management's portfolio in Q1 2026, its #48 holding.
  • Pullen Investment Management first reported a position in Labcorp in Q1 2024 and has held it in 9 quarters since.
  • Pullen Investment Management's Labcorp position peaked at $1.87M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Pullen Investment Management's 13F filing for Q1 2026, filed 15 Apr 2026.